Furthermore, integrating BACE1-AS plasma levels with MRI data from right entorhinal cortex volume and thickness increased specificity (96.15%) and sensitivity (90.91%) as a combinatorial AD biomarker compared to BACE1-AS levels alone [113]. This evidence concerns the gene BACE1 and Alzheimer disease.